InvestorsHub Logo
Followers 9
Posts 402
Boards Moderated 0
Alias Born 04/22/2013

Re: Saltz post# 15664

Wednesday, 06/28/2017 7:45:06 PM

Wednesday, June 28, 2017 7:45:06 PM

Post# of 233655
Saltz:

I don't understand the thinking of Gilead if what you say is accurate. Their is still a vast untapped market for them or anyone that can offer a treatment regime such as PRO-140.

They'll retain current customers, attract defectors from competitors and most importantly welcome current fence sitters & the newly infected to their product.

From what I've gleaned from conference calls and comments on this board, PRO-140 is not that expensive to manufacture and therefore another reason to purchase the company. Can't be that difficult for them to find a way to monetize it-
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News